Topics

"2019 Chemotherapy Induced Pain Clinical Trials Guide Companies" Drugs and Medication Database

17:26 EST 11th December 2019 | BioPortfolio

Here are the most relevant "2019 Chemotherapy Induced Pain Clinical Trials Guide Companies" Drugs and Medications that we have found in our database.

More Information about "2019 Chemotherapy Induced Pain Clinical Trials Guide Companies" on BioPortfolio

We have published hundreds of 2019 Chemotherapy Induced Pain Clinical Trials Guide Companies news stories on BioPortfolio along with dozens of 2019 Chemotherapy Induced Pain Clinical Trials Guide Companies Clinical Trials and PubMed Articles about 2019 Chemotherapy Induced Pain Clinical Trials Guide Companies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 2019 Chemotherapy Induced Pain Clinical Trials Guide Companies Companies in our database. You can also find out about relevant 2019 Chemotherapy Induced Pain Clinical Trials Guide Companies Drugs and Medications on this site too.

Showing "2019 Chemotherapy Induced Pain Clinical Trials Guide Companies" Drugs and Medications 1–25 of 329

Probably Relevant

Oxygen [promptcare companies inc.]

Oxygen

Granisetron hydrochloride [wockhardt limited]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intraveno

Granisetron hydrochloride [wockhardt limited]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intraveno

Granisetron hydrochloride [wockhardt limited]

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intraveno

Possibly Relevant

Nitrogen [haun welding supply, inc.]

Nitrogen

Nitrogen [haun specialty gases, inc.]

Nitrogen

Air [haun specialty gases, inc.]

Air

Helium [haun specialty gases, inc.]

Helium

Oxygen [haun welding supply, inc.]

Oxygen

Oxygen [haun specialty gases, inc.]

Oxygen

Ondansetron [taro pharmaceuticals u.s.a., inc.]

These highlights do not include all the information needed to use ONDANSETRON ORAL SOLUTION safely and effectively. See full prescribing information for ONDANSETRON ORAL SOLUTION ONDANSETRON oral solutionInitial U.S. Approval: 1991

Ondansetron [nucare pharmaceuticals,inc.]

These highlights do not include all the information needed to use ONDANSETRON ORAL SOLUTION safely and effectively. See full prescribing information for ONDANSETRON ORAL SOLUTION ONDANSETRON oral solution Initial U.S. Approval: 1991

Ondansetron [unit dose services]

These highlights do not include all the information needed to use ONDANSETRON ORAL SOLUTION safely and effectively. See full prescribing information for ONDANSETRON ORAL SOLUTION ONDANSETRON oral solutionInitial U.S. Approval: 1991

Ondansetron hydrochloride [taro pharmaceuticals u.s.a., inc.]

These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS ONDANSETRON tablets, for oral use Initial U.S. Approval: 1991

Palonosetron [northstar rx llc]

These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION.  PALONOSETRON HYDROCHLORIDE injection, for Intraveno

Aranesp [amgen inc]

These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP .     ARANESP (darbepoetin alfa )   i njection, for intravenous or subcutaneous use Initial U.S. Approval: 2

Ondansetron [direct rx]

ONDANSETRON

Palonosetron [bluepoint laboratories]

These highlights do not include all the information needed to use palonosetron hydrochloride and effectively. See full prescribing information for palonosetron hydrochloride injection Palonosetron Hydrochloride Injection for Intravenous UseInitial U.S. A

Palonosetron [dr.reddy's laboratories limited]

These highlights do not include all the information needed to use PALONOSETRON HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for PALONOSETRON HYDROCHLORIDE INJECTION.  PALONOSETRON HYDROCHLORIDE, for Intravenous Use Ini

Ondansetron [eywa pharma inc.]

These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON tablets USP, for oral use Initial U.S. Approval: 1991

Ondansetron [h. j. harkins company inc.]

NA

Ondansetron [american health packaging]

These highlights do not include all the information needed to use ONDANSETRON ORAL SOLUTION safely and effectively. See full prescribing information for ONDANSETRON ORAL SOLUTION. ONDANSETRON ORAL SOLUTION Initial U.S. Approval: 1991

Ondansetron [sandoz inc]

These highlights do not include all the information needed to use ONDANSETRON TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS.ONDANSETRON tablets, for oral useInitial U.S. Approval: 1991

Ondansetron [remedyrepack inc.]

These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON tablets USP, for oral use Initial U.S. Approval: 1991

Ondansetron [remedyrepack inc.]

These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON tablets USP, for oral use Initial U.S. Approval: 1991



Quick Search